» Articles » PMID: 37832407

Exploring the Dual Role of CircRNA and PI3K/AKT Pathway in Tumors of the Digestive System

Overview
Date 2023 Oct 13
PMID 37832407
Authors
Affiliations
Soon will be listed here.
Abstract

The interactions among circRNAs, the PI3K/AKT pathway, and their downstream effectors are intricately linked to their functional roles in tumorigenesis. Furthermore, the circRNAs/PI3K/AKT axis has been significantly implicated in the context of digestive system tumors. This axis is frequently abnormally activated in digestive cancers, including gastric cancer, colorectal cancer, pancreatic cancer, and others. Moreover, the overactivation of the circRNAs/PI3K/AKT axis promotes tumor cell proliferation, suppresses apoptosis, enhances invasive and metastatic capabilities, and contributes to drug resistance. In this regard, gaining crucial insights into the complex interaction between circRNAs and the PI3K/AKT pathway holds great potential for elucidating disease mechanisms, identifying diagnostic biomarkers, and designing targeted therapeutic interventions.

Citing Articles

Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities.

Li J, Zhou W, Wang H, Huang M, Deng H MedComm (2020). 2024; 5(12):e70019.

PMID: 39584047 PMC: 11586091. DOI: 10.1002/mco2.70019.


Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer.

Hashemi M, Khosroshahi E, Asadi S, Tanha M, Ghatei Mohseni F, Abdolmohammad Sagha R Noncoding RNA Res. 2024; 10:1-15.

PMID: 39296640 PMC: 11406677. DOI: 10.1016/j.ncrna.2024.08.002.


Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma.

Shao W, Feng Y, Huang J, Li T, Gao S, Yang Y Open Life Sci. 2024; 19(1):20220936.

PMID: 39119480 PMC: 11306965. DOI: 10.1515/biol-2022-0936.


Identification of anti-gastric cancer effects and molecular mechanisms of resveratrol: From network pharmacology and bioinformatics to experimental validation.

Ma Y, Zhang M, Sun Z, Tang H, Wang Y, Liu J World J Gastrointest Oncol. 2024; 16(2):493-513.

PMID: 38425392 PMC: 10900166. DOI: 10.4251/wjgo.v16.i2.493.


Gentiopicroside inhibits the progression of gastric cancer through modulating EGFR/PI3K/AKT signaling pathway.

Chen Q, Zhang T, Li B, Zhu Z, Ma X, Zhang Y Eur J Med Res. 2024; 29(1):47.

PMID: 38212810 PMC: 10782718. DOI: 10.1186/s40001-024-01637-6.